Targeting the CD47-SIRPα signaling axis: current studies on B-cell lymphoma immunotherapy

The Journal of International Medical Research
Jin ZhangWenbin Qian

Abstract

The function of the immune system in cancer initiation and progression has been widely examined. Notably, immunotherapy has become a promising approach for cancer treatment. CD47, a member of the immunoglobulin superfamily, plays an important role in the immune regulation of cancer by binding to SIRPα. Multiple studies have detected high CD47 expression on the surface of tumor cells, which indicates poor prognosis. Treatments that block the interaction of CD47 and SIRPα significantly suppress tumor growth and metastasis through diverse mechanisms, such as phagocytosis, antibody-dependent cellular cytotoxicity, and apoptosis. Recently, several studies have reported increased CD47 expression on different types of lymphoma cells, indicating that the CD47-SIRPα pathway can be used as a therapeutic target in lymphoma. This review focuses on the role of CD47-SIRPα in B-cell lymphoma and discusses promising therapeutic strategies targeting the CD47-SIRPα axis, which yield insights into the immunotherapy of B-cell lymphoma.

References

Feb 27, 2004·Biochemical and Biophysical Research Communications·Yasufumi KikuchiMasayuki Tsuchiya
Nov 18, 2005·Blood·Shyamsundar SubramanianDennis E Discher
Dec 13, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ellen M van BeekTimo K van den Berg
Jul 13, 2006·The Journal of Biological Chemistry·Jeff S IsenbergDavid D Roberts
May 24, 2008·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Min Jung KimDae Seog Heo
Aug 9, 2008·The New England Journal of Medicine·Bruce D Cheson, John P Leonard
Nov 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Xi Wen ZhaoTimo K van den Berg
Feb 9, 2012·Current Opinion in Immunology·Mark P ChaoRavindra Majeti
Mar 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stephen B WillinghamIrving L Weissman
May 22, 2013·Proceedings of the National Academy of Sciences of the United States of America·Diane TsengIrving L Weissman
Jul 3, 2013·Clinical Lymphoma, Myeloma & Leukemia·Jason S StarrHan W Tun
Feb 14, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Terence Kin-Wah LeeIrene Oi Lin Ng
Mar 15, 2014·Journal of Biochemistry·Yoji MurataTakashi Matozaki
Apr 15, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Hiroki GotoSeiji Okada
Sep 1, 2015·Nature Medicine·Xiaojuan LiuMeng Michelle Xu
Sep 10, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Jessica LoTerence Kin Wah Lee
Oct 9, 2015·Anti-cancer Agents in Medicinal Chemistry·Liang Zhang, He Huang
Oct 30, 2015·Proceedings of the National Academy of Sciences of the United States of America·Huimin ZhangGregg L Semenza
Feb 3, 2016·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·F KongY Jia
Jun 9, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexander M LesokhinJohn Timmerman
Nov 26, 2016·Haematologica·Ida HudePaul J Bröckelmann
Jan 18, 2017·JCI Insight·Tadahiko YanagitaTakashi Matozaki
Feb 6, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elie DheillyKrzysztof Masternak
Mar 14, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Kipp Weiskopf
Sep 1, 2017·Nature Reviews. Clinical Oncology·Jennifer N Brudno, James N Kochenderfer
Dec 12, 2017·The New England Journal of Medicine·Sattva S NeelapuWilliam Y Go

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft

Clinical Trials Mentioned

NCT02663518
NCT02367196
NCT02953509
NCT03013218

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
F KongY Jia
Zhongguo shi yan xue ye xue za zhi
Guo-Hong Su, Yu-Lei Zhao
© 2022 Meta ULC. All rights reserved